Impact of a generic substitution reform on patients’ and society's expenditure for pharmaceuticals
- 1 May 2007
- journal article
- research article
- Published by Elsevier in Health Policy
- Vol. 81 (2-3) , 376-384
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Do policy changes in the pharmaceutical reimbursement schedule affect drug expenditures?: Interrupted time series analysis of cost, volume and cost per volume trends in Sweden 1986–2002Health Policy, 2006
- Pharmaceutical policy in Italy: towards a structural change?Health Policy, 2005
- Pharmaceutical Policy regarding Generic Drugs in BelgiumPharmacoEconomics, 2005
- Changes in drug utilization following the outpatient prescription drug cost-sharing program—evidence from Taiwan’s elderlyHealth Policy, 2004
- Why Did Drug Spending Increase During the 1990s?PharmacoEconomics, 2004
- Potential savings from increased use of generic drugs in the elderly: what the experience of Medicaid and other insurance programs means for a Medicare drug benefitPharmacoepidemiology and Drug Safety, 2003
- Outstanding Regulatory Aspects in the European Pharmaceutical MarketPharmacoEconomics, 1999
- What is Germany's experience on reference based drug pricing and the etiology of adverse health outcomes or substitution?Health Policy, 1998
- Providing Incentives to Control Health Care Costs and Remain Competitive in the MarketplaceHealth Marketing Quarterly, 1998
- Payment Restrictions for Prescription Drugs under MedicaidNew England Journal of Medicine, 1987